Geode Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-871,686
| Closed | -$65.6M | – | 5082 |
|
|
2022
Q2 | $65.6M | Sell |
871,686
-41,681
| -5% | -$3.14M | 0.01% | 931 |
|
|
2022
Q1 | $24.5M | Buy |
913,367
+11,984
| +1% | +$322K | ﹤0.01% | 1758 |
|
|
2021
Q4 | $43M | Buy |
901,383
+70,983
| +9% | +$3.39M | 0.01% | 1420 |
|
|
2021
Q3 | $55.2M | Buy |
830,400
+45,344
| +6% | +$3.01M | 0.01% | 1193 |
|
|
2021
Q2 | $61.3M | Buy |
785,056
+107,116
| +16% | +$8.36M | 0.01% | 1134 |
|
|
2021
Q1 | $64.1M | Buy |
677,940
+50,758
| +8% | +$4.8M | 0.01% | 1031 |
|
|
2020
Q4 | $76.4M | Buy |
627,182
+89,462
| +17% | +$10.9M | 0.01% | 827 |
|
|
2020
Q3 | $47M | Buy |
537,720
+166,837
| +45% | +$14.6M | 0.01% | 950 |
|
|
2020
Q2 | $24M | Buy |
370,883
+58,515
| +19% | +$3.78M | 0.01% | 1373 |
|
|
2020
Q1 | $14M | Buy |
312,368
+41,113
| +15% | +$1.84M | ﹤0.01% | 1531 |
|
|
2019
Q4 | $16.9M | Buy |
271,255
+124,236
| +85% | +$7.74M | ﹤0.01% | 1670 |
|
|
2019
Q3 | $5.53M | Buy |
147,019
+29,563
| +25% | +$1.11M | ﹤0.01% | 2324 |
|
|
2019
Q2 | $4.78M | Buy |
+117,456
| New | +$4.78M | ﹤0.01% | 2423 |
|